Senexis Limited Appoints Chairman And Chief Scientific Officer
10/19/2005 5:12:31 PM
Senexis Limited announced today the appointment of Dr Chris Moyses as Non-Executive Chairman and Dr David Scopes as Chief Scientific Officer of the Company. Both directors have joined Senexis' Board to develop and expand the Company's growing pipeline of novel compounds for the treatment of ageing-related diseases, such as type II diabetes, Parkinson's and Alzheimer's Diseases, which have all be linked to a common pathogenic process called "amyloidosis".
comments powered by